Finance

Roʻyxatlar
LH:NYSE
Labcorp Holdings Inc
312,15 US$
-0,65%
(-2,05) 1K
311,84 US$
-0,10% (-0,31)
Yopilgandan keyin
Savdolar yopilgan: 9-okt, 16:00:04 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
LH tikeri uchun statistika yaratilmoqda...
Ochish
313,39 US$
Yuqori
318,18 US$
Past
311,62 US$
Bozor kapitali
25,32 mlrd
Oʻrtacha hajm
776,61 ming
Hajmi
607,86 ming
Dividend
0,92%
Choraklik dividendlar
0,72 US$
Eks-dividend sanasi
29-may, 2026
P/E koeffitsiyenti
25,81
52 haftalik eng yuqori
341,80 US$
52 haftalik eng past
244,52 US$
Aksiya boʻyicha daromad
12,09 US$
Beta
0,88
Muomaladagi aksiyalar
81,10 mln
Xodimlar soni
71 ming
Ochish
313,39 US$
Yuqori
318,18 US$
Past
311,62 US$
Bozor kapitali
25,32 mlrd
Oʻrtacha hajm
776,61 ming
Hajmi
607,86 ming
Dividend
0,92%
Choraklik dividendlar
0,72 US$
Eks-dividend sanasi
29-may, 2026
P/E koeffitsiyenti
25,81
52 haftalik eng yuqori
341,80 US$
52 haftalik eng past
244,52 US$
Aksiya boʻyicha daromad
12,09 US$
Beta
0,88
Muomaladagi aksiyalar
81,10 mln
Xodimlar soni
71 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S. Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program. Wikipedia
Labcorp Holdings Inc haqida
CEOAdam H. Schechter
Xodimlar soni71 ming
Asos solingan1978
Bosh ofislarBurlington, Shimoliy Karolina, Amerika Qo‘shma Shtatlari
SektorHealth care provider
Veb-saytlabcorp.com
Analitik reytinglar
Oxirgi 3 oyda LH aksiyalari boʻyicha reyting bergan 13 tahlilchi xulosasiga koʻra
Sotib olish tavsiya etiladi
Sotib olish
10
Ushlab qolish
3
Sotish
0
12 oylik prognoz
Oxirgi 3 oyda LH uchun 12 oylik narx maqsadlarini taklif qilgan 13 Wall Street tahlilchisi xulosasiga koʻra
Eng yuqori
Joriy 312,15 US$
380,00 US$ (+21,74%)
O‘rtacha
343,50 US$ (+10,04%)
Eng past
306,00 US$ (-1,97%)
Analitik
Tavsiya
Amal
Kutilayotgan narx
Prognoz
Sana
Luke Sergott
Barclays
Hold
Maintained
330,00 US$
+5,7%
10/07/2026
Michael Cherny
Leerink Partners
Buy
Reiterated
-
-
09/23/2026
David S Macdonald
Truist Financial
Buy
Maintained
365,00 US$
+16,9%
09/21/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
340,00 US$
+8,9%
09/11/2026
Kevin Caliendo
UBS
Buy
Maintained
380,00 US$
+21,7%
09/11/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
09/11/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
-
-
08/26/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
355,00 US$
+13,7%
08/10/2026
David Westenberg
Piper Sandler
Hold
Reiterated
309,00 US$
-1%
08/04/2026
Pito Chickering
Deutsche Bank
Hold
Reiterated
306,00 US$
-2%
07/31/2026
Erin Wright
Morgan Stanley
Buy
Maintained
338,00 US$
+8,3%
07/31/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
352,00 US$
+12,8%
07/31/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
360,00 US$
+15,3%
07/30/2026
David Toung
Argus Research
Buy
Maintained
310,00 US$
-0,7%
06/02/2026
Unknown Analyst
Mizuho Securities
Buy
Reiterated
320,00 US$
+2,5%
05/27/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
04/30/2026
Oxirgi hisobot
30-iyl, 2026
Moliya davri
Ch.2 2026
4,99 US$ / 4,77 US$
+4,65%musbat
Taxminiy daromad (USD)
3,73 mlrd / 3,71 mlrd
+0,47%musbat
Q2 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha
Oxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – USD
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
3,56 mlrd
3,52 mlrd
3,54 mlrd
3,73 mlrd
Sotilgan mahsulotning tannarxi
2,54 mlrd
2,52 mlrd
2,52 mlrd
2,62 mlrd
Daromad narxi
2,54 mlrd
2,52 mlrd
2,52 mlrd
2,62 mlrd
Tadqiqot va ishlanmalarga xarajatlar
-
-
-
-
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
552,40 mln
549,70 mln
551,00 mln
577,20 mln
Operatsion xarajatlar
621,90 mln
622,30 mln
626,60 mln
655,30 mln
Jami operatsion xarajatlar
3,16 mlrd
3,14 mlrd
3,15 mlrd
3,27 mlrd
Operatsion daromad
403,20 mln
370,90 mln
387,20 mln
456,70 mln
Boshqa nooperatsion daromad
700,00 ming
1,90 mln
-600,00 ming
-3,50 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
337,00 mln
190,60 mln
319,70 mln
386,40 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
341,30 mln
315,20 mln
333,20 mln
391,50 mln
Daromad soligʻi boʻyicha xarajat
75,50 mln
25,70 mln
41,70 mln
87,30 mln
Amaldagi soliq stavkasi
22,40%
13,48%
13,04%
22,59%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
261,10 mln
164,70 mln
277,80 mln
298,70 mln
Sof foyda marjasi
7,33%
4,68%
7,85%
8,01%
Har bir aksiya foydasi
4,18
4,07
4,25
4,99
Foizlar va investitsiyalardan olingan daromadlar
3,50 mln
3,50 mln
12,20 mln
5,60 mln
Foizlarni toʻlash xarajatlari
-56,00 mln
-55,00 mln
-55,10 mln
-61,10 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-52,50 mln
-51,50 mln
-42,90 mln
-55,50 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
574,20 mln
549,40 mln
560,50 mln
635,70 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
Insayder tranzaksiyalari
Insayder tranzaksiyalari maʼlumotlari tashqi manbalardan olingan. Batafsil
Insayder
Joylashuvi
Turi
Sana
Aksiyalar
Miqdor
1-sahifa
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari